OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/08/2026
Voltar para busca
Dado oficial do USPTO
TASLY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
05/08/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
16/08/2024
Data de registro
27/01/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/01/2026
Última transação
05/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
CN
Examinador
SUK, HAE P
Unidade examinadora
L70
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of an outline of a shaded triangle with two cut-outs in the shape of horizontal bars crossing through the top half; a smaller shaded triangle appears inside; to the right of the triangles appears the literal element "TASLY".
Titulares e representantes
Titulares
Tasly Pharmaceutical Group Co., Ltd.
Representantes
Zhi Dong HSML, P. C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicine for human purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; chemico-pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; biomedicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; herbs for medicinal purposes; medicines made of Chinese traditional medicinal herbs for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; capsules for medicinescapsules sold empty for pharmaceuticals; pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; dietetic food and beverages adapted for medical use; bath preparationsmedicated; medical analgesic preparations; preparations for the treatment of burns; syrups for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; vitamin preparations; sunburn preparations for pharmaceutical purposes; vaccines; detergents for medical purposes; disinfectants for hygiene purposes; digestives for pharmaceutical purposes; mineral water for medical purposes; mineral salts for medical purposes; purgatives; meal for pharmaceutical purposes; flour for pharmaceutical purposes; febrifuges; medicinal tea; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; anthelmintics; pharmaceutical gelatingelatin capsules sold empty for pharmaceuticals; germicides; greases for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal oilsother than essential oils; medicinal herbs; lotions for pharmaceutical purposesanti-bacterial hand washmedicated oral rinsegynecological vaginal wash for medical purposesanorectal wash for medical purposes; ointments for pharmaceutical purposessunburn ointmentsanti-inflammatory ointmentshemorrhoidal ointmentsfrostbite salve for pharmaceutical purposeseye ointments for medical use; pectin for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; herbs teas for medicinal purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; first-aid boxesfilled; medicinal roots; medicinal herbal preparationsmedicated tonics for treating cardiovascular diseaseAMSheart failurecardiovascular and cerebrovascular disease; sedatives; soporifics; sugar for medical purposes; biological preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; medical preparations for slimming purposes; by-products of the processing of cereals for dietetic or medical purposes; medicines for dental purposes; diagnostic preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; medicinal drinks; ferments for pharmaceutical purposes; chemical reagents for medical or veterinary purposes; dietary fiber to aid digestion; enzyme preparations for medical purposes; amino acids for pharmaceutical purposes; mouthwashes for medical purposes; appetite suppressants for medical purposes; adjuvants for medical purposes; weight-reducing aidweight management supplements; pharmaceutical preparations for the treatment of sunburns; food supplementsantioxidants used for medicinal purposes; acne treatment preparation; medicinal herbal preparationslysine electuary for medicinal use; oral rehydration salts; medicinal liquormedicinal alcohol for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; medicinal herbal preparationsginseng electuary for medicinal use; ginseng for medicinal use; medicinal herbal preparationsmedlar; dietetic beverages adapted for medicinal purposesweight-reducing tea; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; nutritional food additives for medical purposes in the nature of natural food extracts derived from fishmeatvegetablesfruits; food for babies; milk powder for infants; air purifying preparations; medicated animal washes; veterinary preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis; medicated animal feed; biocides; vermin destroying preparations; sanitary towels; wadding for medical purposes; medical dressings; rubber for dental purposes; teeth filling material; diaper for pets; raw material medicinepilltabletcapsuleliquid dropsgranule for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS)diabetic retinopathyasthmacancercardiovascular and cerebrovascular diseasecoronary artery diseaseangina pectorismyocardial infarctioncoughdepressiondiabetes and its complicationsenteritisfebrisheadacheheart diseasehepatitishepatopathyhigh blood pressurehypertriglyceridemiahypercholesteremiacombined hyperlipidemiainsomniafatty liver diseaserespiratory tract infectionpsychosisrhinitis
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/08/2026
FIMP
FINAL DISPOSITION PROCESSED
05/08/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/08/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/04/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/01/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
27/01/2026
GPNX
NOTIFICATION PROCESSED BY IB
11/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/12/2025
PUBO
PUBLISHED FOR OPPOSITION
09/12/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/12/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/11/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/11/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
11/11/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/11/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
11/11/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/10/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/10/2025
RFNT
REFUSAL PROCESSED BY IB
28/06/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/06/2025
RFRR
REFUSAL PROCESSED BY MPU
09/06/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/04/2025
CNRT
NON-FINAL ACTION WRITTEN
06/04/2025
DOCK
ASSIGNED TO EXAMINER
22/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
21/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/03/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
21/03/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/03/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TASLY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.